Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma

Name: Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma
Published: 2018
License: Public Domain

M.D. Anderson Cancer Center · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

advanced gastroesophageal junction adenocarcinoma, clinical stage iii esophageal adenocarcinoma ajcc v8, clinical stage iii gastric cancer ajcc v8, clinical stage iv esophageal adenocarcinoma ajcc v8, clinical stage iv gastric cancer ajcc v8, clinical stage iva esophageal adenocarcinoma ajcc v8, clinical stage iva gastric cancer ajcc v8, clinical stage ivb esophageal adenocarcinoma ajcc v8, clinical stage ivb gastric cancer ajcc v8, gastroesophageal junction adenocarcinoma, metastatic gastroesophageal junction adenocarcinoma, pathologic stage iii esophageal adenocarcinoma ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 915019
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.